1488000

Oxymorphone

United States Pharmacopeia (USP) Reference Standard

• 別名: 4,5α-Epoxy-3,14-dihydroxy-17-methylmorphinan-6-one, Dihydroxymorphinone
• 実験式（ヒル表記法）: C₁₇H₁₉NO₄
• CAS番号: 76-41-5
• 分子量: 301.34
• MDL番号: MFCD00079194
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• グレード: pharmaceutical primary standard
• APIファミリー: oxymorphone
• メーカー／製品名: USP
• 薬剤管理: USDEA Schedule I; regulated under CDSA - not available from Sigma-Aldrich Canada; estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal); Kábítószer / Narcotic Drug (Hungary), 78/2022. (XII. 28.) BM rendelet
• drug control: kontrollierte Droge in Deutschland
• アプリケーション: pharmaceutical (small molecule)
• フォーマット: neat
• SMILES記法: N1([C@H]2[C@]3([C@@]4([C@@H](Oc5c4c(ccc5O)C2)C(=O)CC3)CC1)O)C
• InChI: 1S/C17H19NO4/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9/h2-3,12,15,19,21H,4-8H2,1H3/t12-,15+,16+,17-/m1/s1
• InChI Key: UQCNKQCJZOAFTQ-ISWURRPUSA-N

詳細

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

アプリケーション

Oxymorphone USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Oxymorphone Hydrochloride
• Oxymorphone Hydrochloride Extended-Release Tablets
• Oxymorphone Hydrochloride Injection
• Oxymorphone Hydrochloride Tablets

アナリシスノート

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

その他情報

Sales restrictions may apply.

法的情報

German
Dieses Produkt fällt unter das Betäubungsmittelgesetz (BtMG). Für eine Bestellung dieses Produktes ist eine Erlaubnis nach § 3 BtMG zwingend erforderlich, es sei denn, es greift eine Ausnahme von der Erlaubnispflicht nach § 4 oder § 26 BtMG.

English
This product is subject to the German Narcotics Act. A permit under Section 3 of the German Narcotics Act is mandatory for ordering this product unless an exemption from the permit requirement under Section 4 or Section 26 of the German Narcotics Act applies.

安全性情報

• ピクトグラム: GHS07
• シグナルワード: Warning
• 危険有害性情報: H302,H336
• 注意書き: P301 + P312 + P330
• 危険有害性の分類: Acute Tox. 4 Oral - STOT SE 3
• ターゲットの組織: Central nervous system
• 保管分類コード: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable